|
Tue, 08/27/2024 - 18:40 |
Sip and Savor: LUNG FORCE Turquoise Tasting Fundraiser Set for October 24 |
American Lung A... |
|
Thu, 02/01/2024 - 23:26 |
Sanofi launches Beyfortus (nirsevimab-alip) Reservation Program for 2024-2025 RSV season in U.S. |
Sanofi |
|
Tue, 12/13/2022 - 10:00 |
Positive AZD0466 clinical data presented by AstraZeneca (ASX Announcement) |
Starpharma |
|
Tue, 11/29/2022 - 10:32 |
Resilience to Establish a Biomanufacturing Partnership with AstraZeneca and Purchase AstraZenecas Manufacturing Site in West Chester, Ohio |
Resilience |
|
Fri, 11/11/2022 - 11:27 |
UFU recognises top cereal growers of 2022 |
Ulster Farmers Union |
|
Thu, 08/25/2022 - 17:09 |
Medical Product Alert N5/2022: DIPRIVAN |
WHO |
|
Thu, 07/07/2022 - 18:38 |
Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19 |
Wistar Institute |
|
Fri, 04/29/2022 - 04:09 |
AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts |
AstraZeneca |
|
Mon, 02/21/2022 - 07:29 |
Starpharma Interim Report and Half-Year Financial Results (ASX Announcement) |
Starpharma |
|
Mon, 02/14/2022 - 18:30 |
AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies |
BioMed X |
|
Fri, 01/07/2022 - 16:39 |
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006 |
AstraZeneca |
|
Wed, 01/05/2022 - 03:24 |
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed |
AstraZeneca |
|
Mon, 01/03/2022 - 16:44 |
Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators |
Ovid Therapeutics |
|
Wed, 12/29/2021 - 15:33 |
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen |
AstraZeneca |
|
Tue, 12/21/2021 - 06:21 |
Ultomiris regulatory submission accepted under FDA Priority Review in the US for adults with generalised myasthenia gravis |
AstraZeneca |
|
Mon, 12/13/2021 - 16:08 |
Syngenta announces the expiration and final results of the Tender Offer for 4.375% Notes due |
Syngenta |
|
Mon, 12/13/2021 - 04:05 |
AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates |
BioMed X |
|
Mon, 12/06/2021 - 16:04 |
Syngenta Commences Tender Offer for 4.375% Notes due |
Syngenta |
|
Wed, 11/24/2021 - 16:04 |
Syngenta Crop Protection announces PLINAZOLIN technology: setting a new standard in innovative insect control |
Syngenta |
|
Wed, 11/10/2021 - 17:48 |
Glyphic Biotechnologies, Nutrible, and MabSwitch, Inc Named Awardees in CLS Inspire QuickFire Challenge for Diverse Innovators |
CLSA |
|
Wed, 10/27/2021 - 22:53 |
Tracking efficacy of COVID-19 vaccines in cancer patients |
ANU |
|
Tue, 10/19/2021 - 02:32 |
AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design |
BioMed X |
|
Tue, 10/12/2021 - 04:17 |
NeoGenomics Announces Board of Directors' Transition |
NeoGenomics |
|
Wed, 09/29/2021 - 03:15 |
AstraZeneca to fully acquire Caelum Biosciences |
AstraZeneca |
|
Tue, 09/28/2021 - 10:41 |
Race against the virus: the Oxford AstraZeneca COVID-19 vaccine journey |
University of B... |
